AnaptysBio Insider Trades
NASDAQ: ANABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 33 · $6.93M
- Shares bought / sold
- 0 / 139.74K
- Net activity
- Net selling $6.9 million
AnaptysBio insider activity
Over the last 12 months, AnaptysBio insiders reported 53 transactions on SEC Form 4: 0 open-market purchases and 33 sales. Insiders bought $0 and sold $6.9 million worth of stock, for net insider selling of $6.9 million. The largest seller was Faga Daniel, with $2.8 million in reported sales.
The most recent filing shows RENTON HOLLINGS (Director) reporting a transaction in 5,000 shares at $18.03 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ANAB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ANAB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | RENTON HOLLINGSDirector | Sale | 5,000 | $249.37K | Form 4 |
| Oct 1, 2026 | RENTON HOLLINGSDirector | Option exercise | 5,000 | $90.15K | Form 4 |
| Sep 15, 2026 | Orwin John ADirector | Option exercise | 1,300 | — | Form 4 |
| Jun 15, 2026 | Orwin John ADirector | Option exercise | 6,030 | — | Form 4 |
| Jun 15, 2026 | RENTON HOLLINGSDirector | Option exercise | 6,030 | — | Form 4 |
| Jun 15, 2026 | Schmid John P.Director | Option exercise | 6,030 | — | Form 4 |
| Mar 30, 2026 | Schmid John P.Director | Sale | 522 | $29.96K | Form 4 |
| Mar 30, 2026 | Schmid John P.Director | Sale | 7,527 | $426.78K | Form 4 |
| Mar 30, 2026 | Schmid John P.Director | Sale | 12,596 | $701.71K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 100 | $6.60K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 3,038 | $198.07K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 3,155 | $202.52K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 2,592 | $164.20K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 1,012 | $62.90K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 550 | $33.34K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 490 | $29.22K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 3,662 | $214.65K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 2,570 | $148.82K | Form 4 |
| Mar 27, 2026 | Faga DanielPresident, CEO | Sale | 510 | $28.87K | Form 4 |
| Mar 25, 2026 | Faga DanielPresident, CEO | Award | 34,300 | — | Form 4 |
| Feb 11, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 10,000 | $540.00K | Form 4 |
| Feb 11, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Option exercise | 10,000 | $297.00K | Form 4 |
| Jan 15, 2026 | Marquet MagdaDirector | Sale | 1,710 | $83.53K | Form 4 |
| Jan 15, 2026 | Marquet MagdaDirector | Sale | 9,290 | $447.00K | Form 4 |
| Jan 15, 2026 | Marquet MagdaDirector | Option exercise | 11,000 | $287.21K | Form 4 |
| Jan 8, 2026 | Faga DanielPresident, CEO | Sale | 14,281 | $638.50K | Form 4 |
| Jan 8, 2026 | Lizzul Paul F.Chief Medical Officer | Sale | 3,650 | $163.19K | Form 4 |
| Jan 8, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 2,210 | $98.81K | Form 4 |
| Jan 8, 2026 | MULROY DENNISCHIEF FINANCIAL OFFICER | Sale | 2,515 | $112.45K | Form 4 |
| Jan 7, 2026 | MULROY DENNISCHIEF FINANCIAL OFFICER | Sale | 1,908 | $86.07K | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 500 | $23.61K | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 1,841 | $84.93K | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 5,281 | $239.67K | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 2,017 | $90.99K | Form 4 |
| Jan 7, 2026 | Faga DanielPresident, CEO | Sale | 9,202 | $415.10K | Form 4 |
| Jan 7, 2026 | Lizzul Paul F.Chief Medical Officer | Sale | 2,235 | $100.82K | Form 4 |
| Jan 7, 2026 | Faga DanielPresident, CEO | Option exercise | 26,838 | — | Form 4 |
| Jan 7, 2026 | Lizzul Paul F.Chief Medical Officer | Option exercise | 8,525 | — | Form 4 |
| Jan 7, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Option exercise | 5,888 | — | Form 4 |
| Jan 7, 2026 | MULROY DENNISCHIEF FINANCIAL OFFICER | Option exercise | 6,700 | — | Form 4 |
| Jan 6, 2026 | MULROY DENNISCHIEF FINANCIAL OFFICER | Option exercise | 5,245 | — | Form 4 |
| Jan 6, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Option exercise | 5,545 | — | Form 4 |
| Jan 6, 2026 | Faga DanielPresident, CEO | Option exercise | 17,850 | — | Form 4 |
| Jan 6, 2026 | Lizzul Paul F.Chief Medical Officer | Option exercise | 6,145 | — | Form 4 |
| Jan 5, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Sale | 2,983 | $129.04K | Form 4 |
| Jan 5, 2026 | Lizzul Paul F.Chief Medical Officer | Sale | 4,219 | $182.51K | Form 4 |
| Jan 5, 2026 | MULROY DENNISCHIEF FINANCIAL OFFICER | Sale | 3,363 | $145.48K | Form 4 |
| Jan 5, 2026 | Faga DanielPresident, CEO | Sale | 15,309 | $662.27K | Form 4 |
| Jan 3, 2026 | LOUMEAU ERIC JCHIEF LEGAL OFFICER | Option exercise | 7,287 | — | Form 4 |
| Jan 3, 2026 | Lizzul Paul F.Chief Medical Officer | Option exercise | 10,555 | — | Form 4 |
| Jan 3, 2026 | MULROY DENNISCHIEF FINANCIAL OFFICER | Option exercise | 8,292 | — | Form 4 |
| Jan 3, 2026 | Faga DanielPresident, CEO | Option exercise | 34,677 | — | Form 4 |
| Dec 23, 2025 | Ware J. AnthonyDirector | Sale | 3,900 | $193.34K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4